Stocks and Investing Stocks and Investing
Tue, March 22, 2022
Mon, March 21, 2022

Carter Gould Maintained (VOR) at Buy with Decreased Target to $26 on, Mar 21st, 2022


Published on 2024-10-27 20:09:00 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $56 to $26 on, Mar 21st, 2022.

Carter has made no other calls on VOR in the last 4 months.



There are 4 other peers that have a rating on VOR. Out of the 4 peers that are also analyzing VOR, 0 agree with Carter's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Carter


  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $30 on, Wednesday, March 16th, 2022
  • Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $26 on, Friday, December 17th, 2021
  • Jack Allen of "Baird" Initiated at Buy and Held Target at $38 on, Friday, December 3rd, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $30 on, Thursday, December 2nd, 2021
Contributing Sources